Skip to main content

Peer Review reports

From: Impact of medical insurance access negotiation on the utilization of innovative anticancer drugs in China: an interrupted time series analysis

Original Submission
17 Mar 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
5 Sep 2023 Reviewed Reviewer Report
20 Sep 2023 Reviewed Reviewer Report
31 Oct 2023 Author responded Author comments - Qunhong Wu
Resubmission - Version 3
31 Oct 2023 Submitted Manuscript version 3
31 Oct 2023 Author responded Author comments - Qunhong Wu
Resubmission - Version 4
31 Oct 2023 Submitted Manuscript version 4
16 Nov 2023 Author responded Author comments - Qunhong Wu
Resubmission - Version 5
16 Nov 2023 Submitted Manuscript version 5
22 Nov 2023 Reviewed Reviewer Report
28 Nov 2023 Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
29 Nov 2023 Editorially accepted
17 Jan 2024 Article published 10.1186/s12913-023-10393-y

You can find further information about peer review here.

Back to article page